Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Bach

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Pharmaceutics|July 18, 2020
Conjugation of Therapeutic PSD-95 Inhibitors to the Cell-Penetrating Peptide Tat Affects Blood-Brain Barrier Adherence, Uptake, and PermeationMie Kristensen, Krzysztof Kucharz, Eduardo Felipe Alves Fernandes, et al.
The Journal of Biological Chemistry|March 16, 2011
Unique interaction pattern for a functionally biased ghrelin receptor agonistBjørn Sivertsen, Manja Lang, Thomas M Frimurer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damageAnders Bach, Bettina H Clausen, Magda Møller, et al.
Chemmedchem|February 17, 2025
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to LeadJean Quancard, Anders Bach, Chiara Borsari, et al.
Journal of Medicinal Chemistry|October 20, 2022
Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug DiscoveryDilip Narayanan, Kim T Tran, Jakob S Pallesen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTDThor S Thorsen, Kenneth L Madsen, Nelson Rebola, et al.
Scientific Reports|March 13, 2019
Molecular architecture of the Jumonji C family histone demethylase KDM5BJerzy Dorosz, Line Hyltoft Kristensen, Nanda G Aduri, et al.
Neuropharmacology|March 6, 2019
Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitorAnders Bach, Bettina H Clausen, Lotte K Kristensen, et al.
Journal of Medicinal Chemistry|April 5, 2021
Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent CompoundsJakob S Pallesen, Dilip Narayanan, Kim T Tran, et al.
Journal of Medicinal Chemistry|October 19, 2023
Targeting NOX2 with Bivalent Small-Molecule p47phox-p22phox InhibitorsJie Zang, Felix Peters, Yves Cambet, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Pharmaceutics|July 18, 2020
Conjugation of Therapeutic PSD-95 Inhibitors to the Cell-Penetrating Peptide Tat Affects Blood-Brain Barrier Adherence, Uptake, and PermeationMie Kristensen, Krzysztof Kucharz, Eduardo Felipe Alves Fernandes, et al.
The Journal of Biological Chemistry|March 16, 2011
Unique interaction pattern for a functionally biased ghrelin receptor agonistBjørn Sivertsen, Manja Lang, Thomas M Frimurer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damageAnders Bach, Bettina H Clausen, Magda Møller, et al.
Chemmedchem|February 17, 2025
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to LeadJean Quancard, Anders Bach, Chiara Borsari, et al.
Journal of Medicinal Chemistry|October 20, 2022
Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug DiscoveryDilip Narayanan, Kim T Tran, Jakob S Pallesen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTDThor S Thorsen, Kenneth L Madsen, Nelson Rebola, et al.
Scientific Reports|March 13, 2019
Molecular architecture of the Jumonji C family histone demethylase KDM5BJerzy Dorosz, Line Hyltoft Kristensen, Nanda G Aduri, et al.
Neuropharmacology|March 6, 2019
Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitorAnders Bach, Bettina H Clausen, Lotte K Kristensen, et al.
Journal of Medicinal Chemistry|April 5, 2021
Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent CompoundsJakob S Pallesen, Dilip Narayanan, Kim T Tran, et al.
Journal of Medicinal Chemistry|October 19, 2023
Targeting NOX2 with Bivalent Small-Molecule p47phox-p22phox InhibitorsJie Zang, Felix Peters, Yves Cambet, et al.
Pageof 8